Caris Life Sciences, Inc. CAI
NASDAQ · United States · Health Technology
$29.85-0.79 (-2.56%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.00 | 0.01 | -100.0% | $263.71M | +10.8% | +24.2%$16.10→$20.00 |
| Q1 2026 | 2026-05-07 | 0.00 | -0.02 | +100.0% | — | — | -15.6% |
| Q4 2025 | 2026-02-26 | 0.28 | 0.10 | +180.0% | — | — | +10.0%$18.31→$20.14 |
| Q3 2025 | 2025-11-05 | 0.08 | -0.08 | +200.0% | — | — | -21.1%$31.18→$24.61 |
| Q2 2025 | 2025-08-12 | -1.11 | -0.22 | -404.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.